MS vs OMCL · P/E 20, $344.27B cap vs P/E 90, rev $1.11B
Morgan Stanley (MS) versus Omnicell Inc (OMCL) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported OMCL revenue for 2024-12-31 was $1.11B. Net income was $12.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
MS currently screens at market cap $344.27B and trailing P/E 19.8. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
Not investment advice. Open the MS and OMCL stock pages for the full models.
Not investment advice.